Ophthalmic formulation derived from silk protein
AssigneeSilkTears, Inc.
InventorsBrian Lawrence, Jon St. Germain
Life of this patent
Estimating the term…
Loading patent…
AssigneeSilkTears, Inc.
InventorsBrian Lawrence, Jon St. Germain
Estimating the term…
An ophthalmic composition is described for the treatment of dry eye syndrome in a human or mammal. The composition comprises an aqueous solution including an effective amount of silk protein. The aqueous solution comprises from about 0.01% by weight to about 30% by weight of the silk protein. In one embodiment, the silk protein may be fibroin. A method of treating an eye having an ocular surface is also described. The method comprises providing an ophthalmic composition comprising an aqueous solution including an effective amount of silk protein, and administering the ophthalmic composition topically to the ocular surface.
A method to wet the ocular surface of an eye comprising administering an effective amount of an aqueous ophthalmic composition to the ocular surface of the eye, the composition comprising:
A method to wet the ocular surface of an eye comprising administering an effective amount of an aqueous ophthalmic composition to the ocular surface of the eye, the composition comprising:
A method to improve the spreading of an ophthalmic composition across the surface of the eye comprising preparing an ophthalmic composition that comprises a demulcent and a hydrolyzed fibroin protein, and administering the ophthalmic composition to the eye.
Dependencies are inferred from the claim text.